Long-term Outcomes After Bladder-preserving Tri-modality Therapy for Patients with Muscle-invasive Bladder Cancer: An Updated Analysis of the Massachusetts General Hospital Experience
Top Cited Papers
- 9 January 2017
- journal article
- Published by Elsevier BV in European Urology
- Vol. 71 (6), 952-960
- https://doi.org/10.1016/j.eururo.2016.12.020
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Super Extended Versus Extended Pelvic Lymph Node Dissection in Patients Undergoing Radical Cystectomy for Bladder Cancer: A Comparative StudyJournal of Urology, 2011
- Phase I-II RTOG Study (99-06) of Patients With Muscle-Invasive Bladder Cancer Undergoing Transurethral Surgery, Paclitaxel, Cisplatin, and Twice-daily Radiotherapy Followed by Selective Bladder Preservation or Radical Cystectomy and Adjuvant ChemotherapyUrology, 2009
- Defining Early Morbidity of Radical Cystectomy for Patients with Bladder Cancer Using a Standardized Reporting MethodologyEuropean Urology, 2009
- Neoadjuvant Cisplatinum Based Combination Chemotherapy in Patients with Invasive Bladder Cancer: A Combined Analysis of Two Nordic StudiesEuropean Urology, 2004
- RTOG 97-06: Initial report of a Phase I–II trial of selective bladder conservation using TURBT, twice-daily accelerated irradiation sensitized with cisplatin, and adjuvant MCV combination chemotherapyInternational Journal of Radiation Oncology*Biology*Physics, 2003
- Neoadjuvant Chemotherapy plus Cystectomy Compared with Cystectomy Alone for Locally Advanced Bladder CancerThe New England Journal of Medicine, 2003
- The Initial Results in Muscle-Invading Bladder Cancer of RTOG 95-06: Phase I/II Trial of Transurethral Surgery Plus Radiation Therapy with Concurrent Cisplatin and 5-Fluorouracil Followed by Selective Bladder Preservation or Cystectomy Depending on the Initial ResponseThe Oncologist, 2000
- Phase III trial of neoadjuvant chemotherapy in patients with invasive bladder cancer treated with selective bladder preservation by combined radiation therapy and chemotherapy: initial results of Radiation Therapy Oncology Group 89-03.Journal of Clinical Oncology, 1998
- Selective Bladder Preservation by Combination Treatment of Invasive Bladder CancerThe New England Journal of Medicine, 1993
- Combined modality program with possible organ preservation for invasive bladder carcinoma: Results of rtog protocol 85-12International Journal of Radiation Oncology*Biology*Physics, 1993